Trinity Biotech

TRIBNasdaq Ireland Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$6.017 M

$7.40 +0.68%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

374,206,640

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →

#15VolitionrxVNRX$7.34M
#16Q/C TechnologiesQCLS$7.31M
#17Trinity BiotechTRIB$6.02M
#18Cardio DiagnosticsCDIO$5.68M
#19Virax Biolabs GroupVRAX$3.36M

What if Trinity Biotech were worth as much as…

Open the what-if tool →

Gold $30.2T

$37,182,116

Per share 5,024,610× higher

Bitcoin $1.74T

$2,141,909

Per share 289,447× higher

Nvidia $5.52T

$6,783,360

Per share 916,670× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Trinity Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.